I. Belac Lovasić

Is it too expensive to fight cancer? Analysis of incremental costs and benefits of the Croatian National Plan Against Cancer

M. Sekerija, A. Bobinac, E. Vrdoljak, 2021, The European Journal of Health Economics.

Olaparib Outcomes in Patients with BRCA 1-2 Mutated, Platinum-Sensitive, Recurrent Ovarian Cancer in Croatia: A Retrospective Noninterventional Study

Ž. Bajić, E. Vrdoljak, B. Miše, 2020, Journal of oncology.

Comprehensive Genomic Profiling in the Management of Ovarian Cancer—National Results from Croatia

Ž. Bajić, E. Vrdoljak, R. Šeparović, 2022, Journal of personalized medicine.

Optimisation of breast cancer patients' follow‐up – potential way to improve cancer care in transitional countries

N. Dabelić, E. Vrdoljak, M. Petkovic, 2017, European journal of cancer care.

Real-World Efficacy and Safety of Bevacizumab in the First-Line Treatment of Metastatic Cervical Cancer: A Cohort Study in the Total Population of Croatian Patients

Ž. Bajić, E. Vrdoljak, R. Šeparović, 2021, Journal of oncology.

The Challenges and Opportunities of the Implementation of Comprehensive Genomic Profiling in Everyday Clinical Practice with Non-Small Cell Lung Cancer: National Results from Croatia

E. Vrdoljak, S. Tomić, M. Jakopović, 2023, Cancers.

Associations between PIK3CA Mutations and Disease Free Survival in Patients with HR+, HER2− Tumors Treated with Adjuvant Hormonal Therapy: A Real‐World Study in Croatia

Ž. Bajić, R. Šeparović, I. Belac Lovasić, 2024, The Breast Journal.